← Studies & programmes
Emerging treatmentsStudy in peopleResearch, not an established treatment
Refractory-MS AHSCT protocol NCT06228781
Published by MyelinWatch:
Refractory-MS AHSCT protocol NCT06228781 · The sponsor proposes immune-suppressing treatment followed by reinfusion of a person's own blood-forming stem cells (AHSCT) for refractory MS, with a small target enrollment.
What is being studied
The sponsor proposes immune-suppressing treatment followed by reinfusion of a person's own blood-forming stem cells (AHSCT) for refractory MS, with a small target enrollment.
Research stage
Study in people
The study is not yet accepting participants.
What we know so far
The registry describes a planned transplant study that is not yet accepting participants; the cited record has no posted participant or outcome data.
What this means for patients today
This registry entry does not provide a currently joinable study or justify a treatment choice.
- Treatment or approach
- Refractory-MS AHSCT protocol NCT06228781
- Where the study is running
- No site is listed in the record; Greek access is not established.
- Published by MyelinWatch
- Last substantive MyelinWatch update